Singular Genomics Systems, Inc.
SEC CIK 1850906 · OMIC · last insider filing 2025-02-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Barker David L | Director | filed 2021 - 2025 |
| Pellini Michael J | Director | filed 2021 - 2025 |
| Mardis Elaine R | Director | filed 2022 - 2025 |
| Kamdar Kim P. | Director | filed 2021 - 2025 |
| Ryan Jason | Director | filed 2021 - 2025 |
| Spaventa Andrew | Director · Chief Executive Officer | filed 2021 - 2025 |
| Eisenberg Marcia | Director | filed 2023 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Meeter Dalen | Vice President, Finance | filed 2021 - 2025 |
| Glezer Eli N. | Chief Scientific Officer | filed 2021 - 2025 |
| Ghai Jyotsna | Chief Operating Officer | filed 2023 - 2025 |
| Ropp Sam | Chief Commercial Officer | filed 2023 - 2024 |
| Daly David | President and Chief Operating | filed 2021 - 2022 |
| Velarde Jorge | Senior Vice President | filed 2021 - 2021 |
| Durie Daralyn | General Counsel | filed 2021 - 2021 |
| Brancaccio Vincent | Vice President, HR | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.